Stivarga (regorafenib tablets - Bayer) — Cigna

Initial criteria

• Patient age ≥ 18 years
• Patient has recurrent, advanced, inoperable, or metastatic disease
• Patient has tried at least one systemic regimen (examples include doxorubicin, docetaxel, gemcitabine, ifosfamide, dacarbazine, epirubicin, vinorelbine)

Approval duration

1 year